9 days until earnings call
Interact to see
Advertisement
Advertisement
EFAV vs GSK
EFAV vs GSK Comparison
Open Charts EFAV vs GSK
iShares MSCI EAFE Min Vol Factor ETF
Price$85.29
Change+$0.56 (+0.66%)
Volume$418.46K
Net Assets5.24B
EFAV vs GSK Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
EFAV vs. GSK commentary
Oct 20, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EFAV is a Buy and GSK is a Hold.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 50 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 44 | |
P/E GROWTH RATING 1..100 | 14 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| EFAV | GSK | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 77% | 3 days ago 50% |
| Stochastic ODDS (%) | 3 days ago 66% | 3 days ago 55% |
| Momentum ODDS (%) | 3 days ago 78% | 3 days ago 74% |
| MACD ODDS (%) | 3 days ago 69% | 3 days ago 41% |
| TrendWeek ODDS (%) | 3 days ago 77% | 3 days ago 61% |
| TrendMonth ODDS (%) | 3 days ago 73% | 3 days ago 54% |
| Advances ODDS (%) | 3 days ago 76% | 6 days ago 59% |
| Declines ODDS (%) | 7 days ago 77% | 4 days ago 51% |
| BollingerBands ODDS (%) | 3 days ago 79% | 3 days ago 43% |
| Aroon ODDS (%) | 3 days ago 74% | 3 days ago 46% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VPL | 89.81 | 0.33 | +0.37% |
| Vanguard FTSE Pacific ETF | |||
| BCOR | 33.38 | 0.07 | +0.21% |
| Grayscale Bitcoin Adopters ETF | |||
| TJUL | 29.37 | 0.05 | +0.17% |
| Innovator Eq Defnd Protd ETF2 Yr-Jul2027 | |||
| IBIB | 25.32 | N/A | N/A |
| iShares iBonds Oct 2025 Term Tips ETF | |||
| UVXY | 12.10 | -1.65 | -12.00% |
| ProShares Ultra VIX Short-Term Futures | |||
EFAV and
Correlation & Price change
A.I.dvisor indicates that over the last year, EFAV has been loosely correlated with HLN. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EFAV jumps, then HLN could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To EFAV | 1D Price Change % | ||
|---|---|---|---|---|
| EFAV | 100% | +0.66% | ||
| HLN - EFAV | 64% Loosely correlated | +3.04% | ||
| TEF - EFAV | 57% Loosely correlated | +0.78% | ||
| GSK - EFAV | 57% Loosely correlated | +0.32% | ||
| AZN - EFAV | 55% Loosely correlated | +1.03% | ||
| SAN - EFAV | 54% Loosely correlated | -1.31% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y